Clinical Trial Update: A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of an RSV F protein vaccine administered to pregnant individuals to protect newborns from respiratory syncytial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2025-05-06